Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combined use of Aggrastat (tirofiban) and Zocor (simvastatin) for patients with Acute Coronary Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aggrastat (tirofiban)
  • Zocor (simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED